are glp- 1 makers being sued Eli Lilly lawsuit dismissal: Impact on GLP-1 market | Guidepoint posted on the topic Prescription by Algorithm: The Ethical
Description
Already, many GLP-1 users quit within a year, studies suggest often due to side effects, high costs, or insurance issues
And in particular, I really like this at the lower doses
At the start of the trial, the participants had an average hemoglobin A1C ( HbA1c ) of 8.28%
This clinical study evaluated changes in oxidative stress and inflammatory markers after liraglutide treatment in patients with type 2 diabetes
Who can take semaglutide
